AzTrials
AzTrials

AnesthesiaNCT03629743

Correlate of Surface Electroencephalogram (EEG) With Implanted EEG Recordings (ECOG)

An observational study of Anesthesia, run by Stanford University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Improve understanding of the correlation between surface EEG and implanted EEG recordings Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anesthesia
What is being tested?
EEG and ECOG
Type of treatment
Medical device
How many people
20 participants
Where
1 siteUnited States
Study dates
11 Nov 2019to 9 Aug 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stanford Health Care and Clinics

Who may be able to join

  • Male or Female subjects 18 years of age or older.
  • English or Spanish Speaking
  • Subjects who have been previously diagnosed with intractable epilepsy and require implantation of invasive electrophysiological recordings as part of their routine clinical presurgical workup.

Who cannot join

  • Patients with skin abnormalities at the planned application sites that would interfere with sensor or electrode applications.
  • Patients with pre-existing conditions and/or co-morbidities that would prohibit them from participating in the study due to unacceptable risks to their health and well-being, as determined by the Principal Investigator (PI).
  • Patients who the PI deems ineligible at the PI's discretion
  • Pregnant patients

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford University

    Stanford, California, 94305

Other trials in United States

About this study

Improve understanding of the correlation between surface EEG and implanted EEG recordings

Conditions
Anesthesia
Being tested
EEG, ECOG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EEGDevice

    EEG will be collected with Brain Product's VAMP-16 channel EEG Monitor using the accompanying software. (Website with further specifications and product details: https://www.brainproducts.com/productdetails.php?id=15)

  • ECOGDevice

    ECOG will be collected with Nihon Kohden acquisition System and accompanying software and depth electrodes.

Study groups in NCT03629743
Study groupRoleWhat they receive
ECOG and EEG SensorStudy subjects are neurosurgical patients with medically refractory epilepsy who will have implanted with intracranial ECoG electrodes. The electrodes will be used during a period of inpatient monitoring to identify resectable seizure foci.
Receives: Device: EEG; Device: ECOG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Electrocardiogram (EEG) change before, during, and after anesthesia.

    Patient subjective level of consciousness during and after anesthesia administration will be assessed using response to verbal stimuli, response via button press, reported subjective level of consciousness, and/or response to memory tests (i.e. demonstration of explicit memory recall). Around loss and recovery of consciousness time points (e.g. induction or emergence from anesthesia or when patient falls asleep or wakes up during 24 hour postoperative time points) level of consciousness will be assessed in brief intervals (seconds) until patient no longer responds or begins to respond. Data collected before, after, and during seizure activity if a patient loses consciousness or has diminished consciousness may also be compared.

    Measured: Up to 48 hours. Specific time points are dependent on patient clinical events.

Secondary outcomes (2)
  1. Electrocardiogram (EEG) change during any changes in consciousness.

    Scalp and cortical electrical activity collected using EEG and ECOG arrays respectively will be analyzed using standard frequency-derived measures (e.g. spectrograms, Fourier analysis), nonlinear dynamical analyses (e.g. correlation dimension, entropy), network dynamics (e.g. connectivity matrices, path length), and/or machine learning. These measures will include all of the data collected from the start of the implant procedure until 24 hours after the implant procedure has ended. Data collected before, after, and during seizure activity if a patient loses consciousness or has diminished consciousness may also be compared. Reports will included characterization of electrophysiological activity before, during, and after variations in behavioral and subjectively reported consciousness.

    Measured: Up to 48 hours. Specific time points are dependent on patient clinical events.

  2. Electrocardiogram (EEG) change during any seizures.

    Scalp and cortical electrical activity collected using EEG and ECOG arrays respectively will be analyzed using standard frequency-derived measures (e.g. spectrograms, Fourier analysis), nonlinear dynamical analyses (e.g. correlation dimension, entropy), network dynamics (e.g. connectivity matrices, path length), and/or machine learning. Data collected before, after, and during seizure activity if a patient loses consciousness or has diminished consciousness may also be compared. Reports will include characterization and comparison of EEG and ECOG electrophysiological activity and analyses during consciousness transitions and significant time points.

    Measured: Up to 48 hours. Specific time points are dependent on patient clinical events.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2018
  2. Study start11 Nov 2019
  3. Primary completion9 Aug 2026
  4. Study completion9 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03629743
Sponsor's protocol ID
45987
Status last verified
Aug 2026
First submitted
29 May 2018
Last updated
11 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Hashiguchi K, Morioka T, Yoshida F, Miyagi Y, Nagata S, Sakata A, Sasaki T. Correlation between scalp-recorded electroencephalographic and electrocorticographic activities during ictal period. Seizure. 2007 Apr;16(3):238-47. doi: 10.1016/j.seizure.2006.12.010. Epub 2007 Jan 19.

    PubMed 17236792
  • Asano E, Brown EC, Juhasz C. How to establish causality in epilepsy surgery. Brain Dev. 2013 Sep;35(8):706-20. doi: 10.1016/j.braindev.2013.04.004. Epub 2013 May 15.

    PubMed 23684007
  • Smith EH, Liou JY, Davis TS, Merricks EM, Kellis SS, Weiss SA, Greger B, House PA, McKhann GM 2nd, Goodman RR, Emerson RG, Bateman LM, Trevelyan AJ, Schevon CA. The ictal wavefront is the spatiotemporal source of discharges during spontaneous human seizures. Nat Commun. 2016 Mar 29;7:11098. doi: 10.1038/ncomms11098.

    PubMed 27020798
  • Ramantani G, Maillard L, Koessler L. Correlation of invasive EEG and scalp EEG. Seizure. 2016 Oct;41:196-200. doi: 10.1016/j.seizure.2016.05.018. Epub 2016 Jun 10.

    PubMed 27324839
  • Hajat Z, Ahmad N, Andrzejowski J. The role and limitations of EEG-based depth of anaesthesia monitoring in theatres and intensive care. Anaesthesia. 2017 Jan;72 Suppl 1:38-47. doi: 10.1111/anae.13739.

    PubMed 28044337
  • Fahy BG, Chau DF. The Technology of Processed Electroencephalogram Monitoring Devices for Assessment of Depth of Anesthesia. Anesth Analg. 2018 Jan;126(1):111-117. doi: 10.1213/ANE.0000000000002331.

    PubMed 28786839
  • Purdon PL, Sampson A, Pavone KJ, Brown EN. Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures. Anesthesiology. 2015 Oct;123(4):937-60. doi: 10.1097/ALN.0000000000000841.

    PubMed 26275092

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Electrocardiogram (EEG) change before, during, and after anesthesia. (time frame: Up to 48 hours. Specific time points are dependent on patient clinical events.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03629743, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in